Navigation Links
New Breast Cancer Test Could Save Lives

A team of researchers at the University of Bristol is developing a revolutionary new test to detect breast cancer at an early stage. If successful, this test will be effective for women of all ages; given that breast cancer is the largest killer of women between the ages of 35-55 in Europe, the test could have a dramatic effect on the number of deaths from this disease.

The test, which utilises an innovative radar system, will enable women to be tested regularly without the fear of over-exposure to radiation, a problem with existing X-ray tests. Currently, in order to detect cancer at an early stage ?which is extremely important for successful treatment - many women are dependent on self-examination which can prove unreliable. This latest technology has the ability to image through dense breast tissue, and therefore can reach a far wider section of women than X-ray mammography can.

Women below 50 in particular will benefit from this new test, which is much more reliable than X-rays at detecting cancer in this age group. The test is also a much more comfortable procedure than X-rays since it does not involve compressing the breast between plates. This could encourage many more women to be tested regularly for breast cancer, which, according to Cancer Research UK, is the most common cancer for women in this country.

Alan Preece, Professor of Medical Physics at the University of Bristol and one of the lead scientists on this project, said: “Breast cancer is one of the biggest killers that women currently face. Each year, there are over 41,000 new cases in the UK alone. We are very excited about this new technology and the benefits that might come from its use.?/p>

This world-leading research project is funded by the United Bristol Healthcare Trust (UBHT), the University of Bristol’s enterprise initiative and the Sulis Seedcorn fund, which recently awarded over £100,000 of venture capital to the project. Commercialisation of the project has be en driven by SETsquared, the high-tech support programme for very early stage ventures.

SETsquared is part of the enterprise partnership between the universities of Bath, Bristol, Southampton and Surrey. Based alongside the University’s incubation centre at University Gate East, the SETsquared centre in Bristol is actively supporting over 50 nascent entrepreneurs, offering services such as business development, mentoring and cost effective office space.

You can hear the team talking about the project in the next series of BBC Radio 4’s Leading Edge, which is due to air around February or March this year.


'"/>

Source:Bristol University


Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
3. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
4. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
5. Breast Cancer May Be Uniquely Sensitive To Inhibitors Of PI3K Pathway
6. Breast-Cancer Risk Linked to Exposure to Traffic Emissions at Menarche, First Birth
7. Nanoparticle Breast Cancer Drug Approved by FDA
8. Genpathway and Baylor College of Medicine Identify New Genes in Breast Cancer
9. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
10. Affymetrix and bioMerieux Extend Their Agreement on GeneChip(R) Technology to Breast Cancer Diagnostics
11. Antiretroviral Therapy May Prevent HIV Transmission From Breastfeeding Mothers To Infants
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/7/2017)... MINNETONKA, Minn. , Feb. 7, 2017   ... that supports the entire spectrum of clinical research, is ... iMedNet , its innovative, highly flexible and ... iMedNet customers. iMedNet is a ... only provides Electronic Data Capture (EDC), but also delivers ...
(Date:2/3/2017)... Feb. 3, 2017 A new independent identity ... Partners, LLP (IdSP) . Designed to fill a critical ... identity market, founding partners Mark Crego and ... years just in identity expertise that span federal governments, ... leadership. The Crego-Kephart combined expertise has a common theme ...
(Date:1/31/2017)... CAMBRIDGE, Mass. , Jan. 31, 2017 /PRNewswire-USNewswire/ ... develop novel therapies for the treatment of bacterial ... generation set of antibacterial candidates from Pro Bono ... the increased prevalence of multi-drug resistant forms of ... by Cantab Anti Infectives Ltd, a PBB group ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... The Fight Against Cancer Innovation Trust (FACIT) and the ... report that Fusion Pharmaceuticals Inc. (Fusion) has closed a ... – JJDC, Inc. (JJDC) as the lead investor. Additional, ... and Genesys Capital, as well as founding investor FACIT.  ... ...
(Date:2/23/2017)... , Feb. 23, 2017  In Atlanta, it seems ... fashion, and culture intertwine to create an expressive and dynamic ... reflect this energy and contribute to it. ... Hair Fairies seeks to carry on that tradition ... Atlanta salon is the newest of ...
(Date:2/23/2017)... , Feb. 23, 2017  Imanis Life ... product line of oncolytic vaccinia viruses for virotherapy ... as part of Genelux,s proprietary, vaccinia virus-based technology ... excited to enter into a partnership with Genelux ... oncolytic vaccinia viruses for use in research," said ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... that in a published evaluation of multiple immunoassay-based threat detection technologies by ... Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have ...
Breaking Biology Technology: